Australian biotech market today 23.04.09
Thursday, 23 April, 2009
A very flat day’s trading on the healthcare index today, in line with the rest of stocks, which were generally in the positive but volumes were small.
Biota (ASX:BTA) is up 12c on news that royalties from Relenza for the quarter will total $32.3 million.
Circadian (ASX:CIR) was up 3c, as was Clinuvel (ASX:CLV), up 2c to 32c.
Cochlear (ASX:COH) was substantially down again, to $48.3, while Pharmaxis (ASX:PXS) was up a touch.
Diversa (ASX:DVA) was up slightly on its reinstatement to trading.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
